Quality Outcomes

Cystic Fibrosis Australia (CFA) is committed to improving clinical practice and patient outcomes through our clinical improvement programs and research.

We are committed to the goal of extending life expectancy from 47 to 55 years by 2026.


These include the Australian Cystic Fibrosis Data Registry (ACFDR), Peer Reviews, Standards of Care, Infection Control Guidelines, Transition Guidelines and Centre Directors Forums.

Contact your Consumer Representative

Did you know? 

For each of our projects and programs, we have dedicated consumer representatives who provide input into the work Cystic Fibrosis Australia partake in. 


If you would like to submit any feedback or comments to our Consumer Representatives, please complete this form and your reps will take this on board. 

Need More Information?

Scroll to Top